Laboratorio Farmaceutico Erfo SpA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IT0005497885
EUR
1.46
-0.04 (-2.34%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Shedir Pharma Group SpA
Pharmanutra SpA
Enervit SpA
Laboratorio Farmaceutico Erfo SpA
Pierrel SpA
Why is Laboratorio Farmaceutico Erfo SpA ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is Laboratorio Farmaceutico Erfo SpA for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Laboratorio Farmaceutico Erfo SpA
14.96%
0.55
52.31%
Italy FTSE MIB
26.45%
1.30
19.16%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
22.24%
EBIT Growth (5y)
-0.50%
EBIT to Interest (avg)
0.30
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.62
Tax Ratio
17.34%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.23%
ROE (avg)
7.11%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.95
EV to EBIT
16.18
EV to EBITDA
15.06
EV to Capital Employed
1.88
EV to Sales
2.11
PEG Ratio
0.49
Dividend Yield
NA
ROCE (Latest)
3.10%
ROE (Latest)
6.75%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Laboratorio Farmaceutico Erfo SpA
Inventory Turnover Ratio
Highest at 5.43%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 5.61%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Laboratorio Farmaceutico Erfo SpA
Operating Profit
Lowest at EUR 0.09 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (EUR MM)

Operating Profit Margin
Lowest at 3.22 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at EUR 0.13 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (EUR MM)

Net Profit
Lowest at EUR 0.07 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (EUR MM)

EPS
Lowest at EUR 0
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (EUR)

Debt-Equity Ratio
Highest at 0.92 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost
Grown by 108.42% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales